{"transactions":[{"id":255391,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":100000,"derivative":{"exercise_price":60.9046,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255390,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":300000,"derivative":{"exercise_price":47.34,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255389,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":325000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":325000,"derivative":{"exercise_price":58.8446,"expiration_date":"2015-02-03","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255388,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":325000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":975000,"derivative":{"exercise_price":45.28,"expiration_date":"2015-02-03","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255387,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":1300000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":1300000,"derivative":{"exercise_price":43.2646,"expiration_date":"2014-02-11","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255386,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":1300000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":1300000,"derivative":{"exercise_price":29.7,"expiration_date":"2014-02-11","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255385,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":1950000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":1950000,"derivative":{"exercise_price":33.6246,"expiration_date":"2013-02-12","underlying":"Common Stock","underlying_shares":1950000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255384,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":1950000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":650000,"derivative":{"exercise_price":20.06,"expiration_date":"2013-02-12","underlying":"Common Stock","underlying_shares":1950000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255383,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":2600000,"derivative":{"exercise_price":25.0925,"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255382,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":17.3875,"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255381,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":2600000,"derivative":{"exercise_price":18.0475,"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255380,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":13.1719,"expiration_date":"2011-01-17","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255379,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":2600000,"derivative":{"exercise_price":15.625,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255378,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":2600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.9532,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255377,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":6000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":6000000,"derivative":{"exercise_price":8.7188,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":6000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255376,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":6000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.0157,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":6000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255375,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":7870496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":7870496,"derivative":{"exercise_price":8.7188,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":7870496},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255374,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":7870496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.0157,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":7870496},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255373,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"derivative":{"exercise_price":15.625,"expiration_date":"2009-02-17","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255372,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"derivative":{"exercise_price":5.8516,"expiration_date":"2009-02-17","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255371,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":2000000,"derivative":{"exercise_price":15.625,"expiration_date":"2008-01-20","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255370,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"reported_value":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.9922,"expiration_date":"2008-01-20","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255369,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":292000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":292000,"derivative":{"exercise_price":7.5,"expiration_date":"2007-10-27","underlying":"Common Stock","underlying_shares":292000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":255368,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:10:04.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":292000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the highest closing price of the Company's common stock during the recorded grant year for such particular option, except that in the case of certain options with recorded grant years in or prior to 1999, the exercise prices have been increased to the highest closing share price in 2000.  In addition, the exercise prices of certain post-2002 vested options held by the reporting person have been increased to account for the value attributable to the differences between such highest closing share prices and the exercise prices of the previously exercised Subject Options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"derivative":{"exercise_price":5.3829,"expiration_date":"2007-10-27","underlying":"Common Stock","underlying_shares":292000},"source":{"system":"sec-edgar","filing":"0001181431-06-062886","document":"rrd135936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062886/rrd135936.xml","form_type":"4"}},{"id":266746,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-02-27T21:04:30.000Z","date":"2006-02-23","kind":"exercise","acquired":false,"shares":729504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13870496,"derivative":{"exercise_price":5.0157,"exercise_date":"2000-10-13","expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":729504},"source":{"system":"sec-edgar","filing":"0000731766-06-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000027/edgardoc.xml","form_type":"4"}},{"id":266745,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-02-27T21:04:30.000Z","date":"2006-02-23","kind":"exercise","acquired":false,"shares":1570496,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"1999-10-29","expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":1570496},"source":{"system":"sec-edgar","filing":"0000731766-06-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000027/edgardoc.xml","form_type":"4"}},{"id":266744,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2006-02-27T21:04:30.000Z","date":"2006-02-23","kind":"sale","acquired":false,"shares":2300000,"price":59.1,"value":135930000.0,"ownership":{"direct":true},"balance_after":644862,"source":{"system":"sec-edgar","filing":"0000731766-06-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000027/edgardoc.xml","form_type":"4"}},{"id":266743,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2006-02-27T21:04:30.000Z","date":"2006-02-23","kind":"exercise","acquired":true,"shares":729504,"price":5.0157,"value":3658973.2128,"ownership":{"direct":true},"balance_after":2944862,"source":{"system":"sec-edgar","filing":"0000731766-06-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000027/edgardoc.xml","form_type":"4"}},{"id":266742,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2006-02-27T21:04:30.000Z","date":"2006-02-23","kind":"exercise","acquired":true,"shares":1570496,"price":5,"value":7852480.0,"ownership":{"direct":true},"balance_after":2215358,"source":{"system":"sec-edgar","filing":"0000731766-06-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000027/edgardoc.xml","form_type":"4"}},{"id":267982,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-02-02T22:14:58.000Z","date":"2006-01-31","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":400000,"derivative":{"exercise_price":59.42,"exercise_date":"2007-01-31","expiration_date":"2016-01-31","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000731766-06-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000022/edgardoc.xml","form_type":"4"}},{"id":279494,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-05-04T21:25:13.000Z","date":"2005-05-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 1/1/2006."}],"balance_after":200000,"derivative":{"exercise_price":94.68,"exercise_date":"2006-01-01","expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000731766-05-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000071/edgardoc.xml","form_type":"4"}},{"id":282129,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-02-07T21:59:53.000Z","date":"2005-02-03","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 1/1/2006."}],"balance_after":650000,"derivative":{"exercise_price":90.56,"expiration_date":"2015-02-03","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000731766-05-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000039/edgardoc.xml","form_type":"4"}},{"id":284327,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair & CEO, UnitedHealth Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-12-01T17:46:22.000Z","date":"2004-11-30","kind":"exercise","acquired":false,"shares":1000000,"price":80.6,"value":80600000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.7188,"exercise_date":"1998-01-01","expiration_date":"2007-02-11","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000731766-04-000186","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000186/edgardoc.xml","form_type":"4"}},{"id":284326,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair & CEO, UnitedHealth Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-12-01T17:46:22.000Z","date":"2004-11-30","kind":"exercise","acquired":false,"shares":654000,"price":80.6,"value":52712400.0,"ownership":{"direct":true},"balance_after":146000,"derivative":{"exercise_price":10.7657,"exercise_date":"1999-02-16","expiration_date":"2007-10-27","underlying":"Common Stock","underlying_shares":654000},"source":{"system":"sec-edgar","filing":"0000731766-04-000186","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000186/edgardoc.xml","form_type":"4"}},{"id":284325,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair & CEO, UnitedHealth Grp"}}],"security":"Common Stock","published_at":"2004-12-01T17:46:22.000Z","date":"2004-11-30","kind":"sale","acquired":false,"shares":1654000,"price":80.6,"value":133312400.0,"ownership":{"direct":true},"balance_after":322425,"source":{"system":"sec-edgar","filing":"0000731766-04-000186","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000186/edgardoc.xml","form_type":"4"}},{"id":284324,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair & CEO, UnitedHealth Grp"}}],"security":"Common Stock","published_at":"2004-12-01T17:46:22.000Z","date":"2004-11-30","kind":"exercise","acquired":true,"shares":654000,"price":10.7657,"value":7040767.8,"ownership":{"direct":true},"balance_after":1976425,"source":{"system":"sec-edgar","filing":"0000731766-04-000186","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000186/edgardoc.xml","form_type":"4"}},{"id":284323,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair & CEO, UnitedHealth Grp"}}],"security":"Common Stock","published_at":"2004-12-01T17:46:22.000Z","date":"2004-11-30","kind":"exercise","acquired":true,"shares":1000000,"price":11.7188,"value":11718800.0,"ownership":{"direct":true},"balance_after":1322425,"source":{"system":"sec-edgar","filing":"0000731766-04-000186","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000186/edgardoc.xml","form_type":"4"}},{"id":295182,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-02-13T18:24:01.000Z","date":"2004-02-11","kind":"other","acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable at the rate of 25% per year over a period of four years commencing on January 1, 2005."}],"balance_after":1300000,"derivative":{"exercise_price":59.4,"expiration_date":"2014-02-11","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001209191-04-009665","document":"bmn82944_bmn2wwm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919104009665/bmn82944_bmn2wwm.xml","form_type":"4"}},{"id":303026,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":false,"shares":174752,"price":10,"value":1747520.0,"ownership":{"direct":true},"balance_after":785248,"derivative":{"exercise_price":10,"exercise_date":"1999-10-26","expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":174752},"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303025,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":false,"shares":125248,"price":9.4688,"value":1185948.2624,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.4688,"exercise_date":"1995-05-10","expiration_date":"2004-04-20","underlying":"Common Stock","underlying_shares":125248},"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303024,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":false,"shares":600000,"price":9,"value":5400000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"1996-05-08","expiration_date":"2005-05-08","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303023,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":false,"shares":1000000,"price":8.4375,"value":8437500.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.4375,"exercise_date":"1997-01-01","expiration_date":"2006-07-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303022,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"sale","acquired":false,"shares":1900000,"price":53.13,"value":100947000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Indirect holdings = 3,151 shares held by 401(k)"}],"balance_after":322424,"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303021,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":true,"shares":174752,"price":10,"value":1747520.0,"ownership":{"direct":true},"balance_after":2222424,"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303020,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":true,"shares":1000000,"price":8.4375,"value":8437500.0,"ownership":{"direct":true},"balance_after":2047672,"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303019,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":true,"shares":600000,"price":9,"value":5400000.0,"ownership":{"direct":true},"balance_after":1047672,"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}},{"id":303018,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13613,"kind":"person","name":"MCGUIRE WILLIAM W","position":1,"cik":"0001024363","reported_name":"MCGUIRE WILLIAM W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2003-07-31T16:38:44.000Z","date":"2003-07-30","kind":"other","acquired":true,"shares":125248,"price":9.4688,"value":1185948.2624,"ownership":{"direct":true},"balance_after":447672,"source":{"system":"sec-edgar","filing":"0001209191-03-014570","document":"bmn78088_bmn13wwm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103014570/bmn78088_bmn13wwm.xml","form_type":"4"}}]}